Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
Seismic Therapeutic has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Seismic Therapeutic's investors include Lightspeed Venture Partners, Bessemer Venture Partners, Gaingels, Samsara BioCapital, Polaris Partners.
Seismic Therapeutic is headquartered in Watertown, United States.
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
Seismic Therapeutic is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seismic Therapeutic — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/seismic-therapeutic. Accessed September 30, 2026.
VCBacked. (2024). Seismic Therapeutic — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/seismic-therapeutic
{{cite web |title=Seismic Therapeutic — Funding & Investors |url=https://www.vcbacked.co/company/seismic-therapeutic |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated